PAUL GEER

• Process Engineer, CPhT, CSPT
• Ensured precision and safety in the preparation of intravenous admixtures using sterile techniques in laminar flow hoods.
• Developed and revised SOPs to align with USP, FDA, NABP, and cGMP guidelines.
• Coordinated with FDA, NABP, and MN Board of Pharmacy during inspections, addressing operational issues with a focus on mechanical and process compliance.
• Designed, implemented, controlled, and optimized the product's compounding phase from start to finish.
• Collaborated with stakeholders to establish key performance indicators aligned with strategic objectives while ensuring regulatory compliance.

2024 Current Projects:

• 8,700 sq. ft. pharmaceutical facility expansion to include new office space, new R&D lab, new cleanroom installation, additional production bays, and additional warehouse space. The project kicked off in December 2023, and it is scheduled for completion in spring 2025.
• β-Lactam Powder handling process resulted in an increase of 13% (2.2M savings on active pharmaceuticals loss), a 99% reduction in aerosolized powders, a 0 lift process, and floor space recovery of 1,800 sq ft.
• Collaborated with KAMP Automation to develop a custom automation system for a proprietary sterile injectable product. This project will increase efficiency and capacity to more than 3X, while eliminating operator-introduced risk of contamination of the finished product (530K). Reduction of labor by 50%, and 100% elimination of puncture and exposure injuries. All performance qualifications were completed in September 2024, and the system was placed online on October 2, 2024.

2023 Completed Projects:

• Designed large-bore spikes for our sterile cleanroom process. This project was due to a market shortage of sterile I.V. spikes. This resulted in consumable savings of $27,000 annually. Redesign (late 2023) of spikes for the sterile automation system.
• Led the MW Watermark filter press project, achieving a 17% recovery improvement and an 87% efficiency boost, resulting in $300,000 in last quarter revenue. Exceeded the 2024 sales forecast of 3.25 million in the product's first year post-launch.
• R&D Lab Mass Spec instrument purchase (420K). This will allow us full, real-time quantitative analysis of existing and developing products.
• Projects completed in 2022 include full buildout of R&D Laboratory from a compounding bay(140k), Installation of large capacity autoclave (102k), Installation of site-wide compressed air system (68k) and 3PL offsite warehouse storage
• Project manager and principal SME for VetRx (VPS) relocation in 2008. Design/build of new 10,000 sq ft facility with ISG Architects and Vos Construction (1.5M)

• Line technician involved with building RO elements, which included manual and automation rolling systems (AMEC), trimming, fiberglass rolling, chamfering, testing and packaging
• Operated RO test equipment to ensure finished goods meet specifications
• Member of the Emergency Response team
• CPR and EMR Certified through Red Cross(no longer current)